Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $2.18 in the prior trading day, Aclaris Therapeutics Inc (NASDAQ: ACRS) closed at $2.05, down -5.96%. In other words, the price has decreased by -$5.96 from its previous closing price. On the day, 0.74 million shares were traded. ACRS stock price reached its highest trading level at $2.29 during the session, while it also had its lowest trading level at $2.03.
Ratios:
Our goal is to gain a better understanding of ACRS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.03 and its Current Ratio is at 7.03. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On October 03, 2023, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $22.Evercore ISI initiated its Outperform rating on October 03, 2023, with a $22 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 05 ’24 when Leonard Braden Michael bought 206,025 shares for $1.24 per share. The transaction valued at 256,357 led to the insider holds 14,250,000 shares of the business.
Leonard Braden Michael bought 167,544 shares of ACRS for $216,400 on Aug 02 ’24. The 10% Owner now owns 14,043,975 shares after completing the transaction at $1.29 per share. On Jul 30 ’24, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 173,730 shares for $1.30 each. As a result, the insider paid 226,370 and bolstered with 13,776,421 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACRS now has a Market Capitalization of 146433328 and an Enterprise Value of 20956432. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.08 while its Price-to-Book (P/B) ratio in mrq is 1.12. Its current Enterprise Value per Revenue stands at 0.774 whereas that against EBITDA is -0.337.
Stock Price History:
Over the past 52 weeks, ACRS has reached a high of $2.72, while it has fallen to a 52-week low of $0.67. The 50-Day Moving Average of the stock is 37.58%, while the 200-Day Moving Average is calculated to be 60.39%.
Shares Statistics:
The stock has traded on average 560.06K shares per day over the past 3-months and 1130270 shares per day over the last 10 days, according to various share statistics. A total of 70.89M shares are outstanding, with a floating share count of 67.57M. Insiders hold about 5.41% of the company’s shares, while institutions hold 70.04% stake in the company. Shares short for ACRS as of 1730332800 were 2409457 with a Short Ratio of 4.30, compared to 1727654400 on 1727320. Therefore, it implies a Short% of Shares Outstanding of 2409457 and a Short% of Float of 4.03.
